[1] 胡中杰, 张晶. 我国非酒精性脂肪性肝病的研究现状. 临床肝胆病杂志, 2016,32:552-556.
[2] Mazzoccoli G, Vinciguerra M, Oben J, et al. Non-alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity. Liver Int,2014,34:1133-1152.
[3] 丛乃霞, 刘贺, 梁少辉. 生物节律的研究进展.中国疗养医学,2016,25:809-812.
[4] Reinke H, Asher G. Circadian clock control of liver metabolic functions. Gastroenterology,2016,150:574-580.
[5] Takahashi JS. Transcriptional architecture of the mammalian circadian clock. Nat Rev Genet,2017,18:164-179.
[6] Voigt RM, Forsyth CB, Green SJ, et al. Circadian rhythm and the gut microbiome. Int Rev Neurobiol,2016,131:193-205.
[7] Kumar JP, Challet E, Kalsbeek A. Circadian rhythms in glucose and lipid metabolism in nocturnal and diurnal mammals. Mol Cell Endocrinol,2015, 418:74-88.
[8] Lamia KA, Storch KF, Weitz CJ.Physiological significance of a peripheral tissue circadian clock. Proc Natl Acad Sci USA,2008,105:15172-15177.
[9] Rudic RD, McNamara P, Curtis AM, et al. BMAL1 and CLOCK, two essential components of the circadianclock, are involved in glucose homeostasis. LoS Biol,2004,2:e377.
[10] Zhang EE, Liu Y, Dentin R, et al. Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis. Nat Med,2010,16:1152-1156.
[11] Lamia KA, Papp SJ, Yu RT, et al. Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. Nature,2011,480:552-556.
[12] 吕垣澄, 吴晓晖. 动物隐花色素研究进展. 遗传,2014,36:864-870.
[13] Adamovich Y, Aviram R, Asher G. The emerging roles oflipids in circadian control. Biochim Biophys Acta,2015,1851:1017-1025.
[14] Le Martelot G, Claudel T, Gatfield D, et al. REV-ERBalphaparticipates in circadian SREBP signaling and bile acidhomeostasis. PloS Biol, 2009,7:e1000181.
[15] Eckel-Mahan KL, Patel VR, Mohney RP,et al. Coordination of the transcriptome and metabolome by thecircadian clock. Proc Natl Acad Sci USA,2012,109:5541-5546.
[16] Tong X, Yin L. Circadian rhythms in liver physiology and liver diseases. Compr Physiol,2013,3:917-940.
[17] Raspe E, Duez H, Mansen A, et al. Identification of Reverbalpha as a physiological repressor of apoC-III genetranscription. J Lipid Res, 2002,43:2172-2179.
[18] Hoogerwerf WA. Role of biological rhythms in gastrointestinal health and disease. Rev Endocr Metab Disord,2009,10:293-300.
[19] Yki-Järvinen H.Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol,2014, 2:901-910.
[20] Bernsmeier C, Weisskopf DM, Pflueger MO, et al. Sleep disruption and daytime sleepiness correlating with disease severity and insulin resistance in non-alcoholic fatty liver disease: a comparison with healthy controls. Plos One,2015,10:e0143293.
[21] Adamovich Y, Rousso-Noori L, Zwighaft Z, et al. Circadian clocks and feeding time regulate the oscillations and levels of hepatic triglycerides. Cell Metab,2014,19:319-330.
[22] Turek FW, Joshu C, Kohsaka A,et al. Obesity and metabolic syndrome in circadian clock mutant mice. Science,2005,308:1043-1045.
[23] Ando H, Yanagihara H, Hayashi Y, et al. Rhythmic messenger ribonucleic acid expression of clock genes and adipocytokines in mouse visceral adipose tissue.Endocrinology,2005,146:5631-5636.
[24] Ando H, Takamura T, Matsuzawa-Nagata N, et al. The hepatic circadian clock is preserved in a lipid-induced mouse model of non-alcoholic steatohepatitis. Biochem Biophys Res Commun,2009,380:684-688.
[25] Yu T, Shibata S. Circadian rhythms of liver physiology and disease: experimental and clinical evidence. Nat Rev Gastroenterol Hepatol, 2016, 13:217. |
